HCP access

Sales & Marketing

Evolving HCP access requires a new connected approach to bui...

Specialty medicines – treatments designed for very small patient populations with complex and rare conditions – are on the rise.

R&D

Chris Moore from Veeva Systems interview with Nicole Raleigh

In conversation with Chris Moore: Declining HCP access

During the 10th anniversary of the Veeva R&D and Quality Summit, held in Madrid in June, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to d

Market Access

Shifting HCP access calls for new field tactics globally

Even before COVID-19 pushed access to an all-time low, access had been declining

Evolving HCP access requires a new connected approach to bui...

In conversation with Chris Moore: Declining HCP access

Shifting HCP access calls for new field tactics globally

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks